Latest DNA gyrase Stories
In research at SRI International, scientists evaluating new drug targets against tuberculosis (TB) recently validated the preclinical effectiveness of a target that could rapidly eliminate infections and potentially shorten treatment time.
Scientists are collaborating on a new international research project to identify antibiotics that can kill tuberculosis and fight resistant strains.
An antibiotic that binds to a well-established target in a novel and unexpected way could be the inspiration for designing new, more potent antibacterial drugs.
- A political dynamiter.